Cite
HARVARD Citation
Francolini, G. et al. (n.d.). PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach. Radiotherapy and oncology. pp. S683-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Francolini, G. et al. (n.d.). PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach. Radiotherapy and oncology. pp. S683-. [Online].